2017 Form 10-K Financial Statement
#000119312518117053 Filed on April 13, 2018
Income Statement
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $15.09M | -$4.900M | $4.593M |
YoY Change | 228.52% | -278.83% | -56.71% |
% of Gross Profit | |||
Research & Development | $6.067M | -$3.850M | $11.40M |
YoY Change | -46.76% | -179.38% | -51.74% |
% of Gross Profit | |||
Depreciation & Amortization | $260.0K | -$100.0K | $3.000K |
YoY Change | 8566.67% | -47.37% | -97.2% |
% of Gross Profit | |||
Operating Expenses | $21.16M | -$8.740M | $31.87M |
YoY Change | -33.61% | -215.15% | -6.88% |
Operating Profit | -$23.04M | -$15.99M | |
YoY Change | 44.1% | -53.28% | |
Interest Expense | -$460.0K | -$13.35M | -$1.170M |
YoY Change | -60.68% | -770.85% | -392.5% |
% of Operating Profit | |||
Other Income/Expense, Net | -$23.50M | -$5.710M | $21.01M |
YoY Change | -211.86% | -1397.73% | -580.65% |
Pretax Income | -$23.50M | -$8.510M | -$17.68M |
YoY Change | 32.92% | -18.49% | -54.19% |
Income Tax | $253.0K | $0.00 | $1.000K |
% Of Pretax Income | |||
Net Earnings | -$23.75M | $350.0K | -$17.68M |
YoY Change | 34.35% | -101.78% | -72.33% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$475.0M | $5.833M | -$884.0M |
COMMON SHARES | |||
Basic Shares Outstanding | 217.0M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.320M | $6.000M | $5.960M |
YoY Change | -61.07% | -79.8% | -79.95% |
Cash & Equivalents | $2.320M | $5.962M | $5.960M |
Short-Term Investments | |||
Other Short-Term Assets | $10.77M | $400.0K | $420.0K |
YoY Change | 2464.29% | -98.33% | -98.24% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $13.09M | $6.379M | $6.380M |
YoY Change | 105.17% | -88.1% | -88.1% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $199.0K | ||
YoY Change | -40.6% | ||
Goodwill | $5.898M | ||
YoY Change | 0.0% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $930.0K | $0.00 | $40.00K |
YoY Change | 2225.0% | -100.0% | -76.47% |
Total Long-Term Assets | $20.44M | $41.00K | $40.00K |
YoY Change | 51000.0% | -99.86% | -99.86% |
TOTAL ASSETS | |||
Total Short-Term Assets | $13.09M | $6.379M | $6.380M |
Total Long-Term Assets | $20.44M | $41.00K | $40.00K |
Total Assets | $33.53M | $6.420M | $6.420M |
YoY Change | 422.27% | -92.18% | -92.18% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $11.69M | $840.0K | $0.00 |
YoY Change | -47.4% | -100.0% | |
Accrued Expenses | $2.790M | $4.049M | $3.820M |
YoY Change | -26.96% | -23.49% | -27.79% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $8.380M | $16.40M | $1.710M |
YoY Change | 390.06% | 246.0% | -63.92% |
Total Short-Term Liabilities | $24.57M | $5.758M | $5.760M |
YoY Change | 326.56% | -89.91% | -89.91% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $2.610M | $5.700M | $5.660M |
YoY Change | -53.89% | ||
Other Long-Term Liabilities | $2.600M | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $5.210M | $5.700M | $5.660M |
YoY Change | -7.95% | -7.82% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $24.57M | $5.758M | $5.760M |
Total Long-Term Liabilities | $5.210M | $5.700M | $5.660M |
Total Liabilities | $31.46M | $11.42M | $11.42M |
YoY Change | 175.48% | -83.36% | -83.36% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$30.43M | ||
YoY Change | |||
Common Stock | $25.44M | ||
YoY Change | -91.43% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $3.849M | ||
YoY Change | 0.0% | ||
Treasury Stock Shares | 33.75K shares | ||
Shareholders Equity | $2.070M | -$4.997M | -$5.000M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $33.53M | $6.420M | $6.420M |
YoY Change | 422.27% | -92.18% | -92.18% |
Cashflow Statement
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$23.75M | $350.0K | -$17.68M |
YoY Change | 34.35% | -101.78% | -72.33% |
Depreciation, Depletion And Amortization | $260.0K | -$100.0K | $3.000K |
YoY Change | 8566.67% | -47.37% | -97.2% |
Cash From Operating Activities | -$10.99M | $25.07M | -$11.85M |
YoY Change | -7.27% | -264.07% | -75.39% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $6.000K | ||
YoY Change | -96.08% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $12.16M | $960.0K | -$90.00K |
YoY Change | -13611.11% | -91.5% | -100.85% |
Cash From Investing Activities | $12.16M | $970.0K | -$85.00K |
YoY Change | -14403.53% | -91.35% | -100.82% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $0.00 | ||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $6.007M | $33.53M | |
YoY Change | -82.09% | -29.28% | |
Debt Paid & Issued, Net | $473.0K | $5.579M | |
YoY Change | -91.52% | 42.65% | |
Cash From Financing Activities | $5.534M | -16.26M | 16.50M |
YoY Change | -66.46% | 1526.0% | -62.37% |
NET CHANGE | |||
Cash From Operating Activities | -$10.99M | 25.07M | -11.85M |
Cash From Investing Activities | $12.16M | 970.0K | -85.00K |
Cash From Financing Activities | $5.534M | -16.26M | 16.50M |
Net Change In Cash | $6.703M | 9.780M | 4.565M |
YoY Change | 46.83% | -293.28% | -24.92% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$10.99M | $25.07M | -$11.85M |
Capital Expenditures | $6.000K | ||
Free Cash Flow | -$11.86M | ||
YoY Change | -75.46% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
6572542 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1268489 | shares |
CY2017Q2 | dei |
Entity Public Float
EntityPublicFloat
|
21640272 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1397000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-12262000 | |
CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4049000 | |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
6379000 | |
CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1077000 | |
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
25434000 | |
CY2016Q4 | us-gaap |
Assets
Assets
|
6420000 | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5962000 | |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
CY2016Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1709000 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1268489 | shares |
CY2016Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
7368000 | |
CY2016Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
5659000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3549000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
41000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
|
81000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3145000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
295000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3508000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
28000 | |
CY2016Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
41000 | |
CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
249000 | |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
11417000 | |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6420000 | |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5758000 | |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
227000 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
332000 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
85000 | |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30431000 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
55000 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
52.94 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4997000 | |
CY2016Q4 | sls |
Contract Research Payable
ContractResearchPayable
|
2496000 | |
CY2016Q4 | sls |
Impact On Tax Provision From Unrecognized Tax Benefits
ImpactOnTaxProvisionFromUnrecognizedTaxBenefits
|
44000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5766891 | shares |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Minority Interest Ownership Percentage By Noncontrolling Owners
MinorityInterestOwnershipPercentageByNoncontrollingOwners
|
0.325 | pure |
CY2017Q4 | us-gaap |
Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
|
0.675 | pure |
CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
14900000 | |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3201000 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13087000 | |
CY2017Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
11907000 | |
CY2017Q4 | us-gaap |
Accrued Exchange Fee Rebate Current
AccruedExchangeFeeRebateCurrent
|
223000 | |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1744000 | |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
56254000 | |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
11691000 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
33526000 | |
CY2017Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
1294000 | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2319000 | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5766891 | shares |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
1662000 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
963000 | shares |
CY2017Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
1619000 | shares |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5766891 | shares |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3438000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6423000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
1765000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
|
395000 | |
CY2017Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
10200000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1028000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
345000 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1673000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
3700000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4658000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
3700000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2550000 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
|
3438000 | |
CY2017Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
925000 | |
CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
566000 | |
CY2017Q4 | us-gaap |
Goodwill
Goodwill
|
1914000 | |
CY2017Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
17600000 | |
CY2017Q4 | us-gaap |
Interest Receivable
InterestReceivable
|
800000 | |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
31456000 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
33526000 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
24569000 | |
CY2017Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
2603000 | |
CY2017Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
10988000 | |
CY2017Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
8377000 | |
CY2017Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
1300000 | |
CY2017Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
2611000 | |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
191000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
299000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
76000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
223000 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
337000 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
10431000 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54185000 | |
CY2017Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
7.86 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
10000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1240.55 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1240.55 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2070000 | |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
72000 | |
CY2017Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
426000 | |
CY2017Q4 | sls |
Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
|
1294000 | |
CY2017Q4 | sls |
Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
|
1309000 | |
CY2017Q4 | sls |
Warrant Liability
WarrantLiability
|
1309000 | |
CY2017Q4 | sls |
Share Based Compensation Arrangement By Share Based Payment Award Options Canceled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledIntrinsicValue
|
0 | |
CY2017Q4 | sls |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue
|
0 | |
CY2017Q4 | sls |
Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
|
2105000 | |
CY2017Q4 | sls |
Restricted Cash And Cash Equivalents Fair Value Disclosure
RestrictedCashAndCashEquivalentsFairValueDisclosure
|
10245000 | |
CY2017Q4 | sls |
Deferred Tax Asset Net Operating Loss Carryforwards Indefinite Life
DeferredTaxAssetNetOperatingLossCarryforwardsIndefiniteLife
|
1800000 | |
CY2017Q4 | sls |
Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
|
1309000 | |
CY2017Q4 | sls |
Number Of Stock Options Granted
NumberOfStockOptionsGranted
|
0 | Option |
CY2017Q4 | sls |
Contract Research Payable
ContractResearchPayable
|
51000 | |
CY2017Q4 | sls |
Debt Instrument Covenant Prepay Lesser Accrued And Unpaid Interest
DebtInstrumentCovenantPrepayLesserAccruedAndUnpaidInterest
|
18500000 | |
CY2017Q4 | sls |
Impact On Tax Provision From Unrecognized Tax Benefits
ImpactOnTaxProvisionFromUnrecognizedTaxBenefits
|
28000 | |
CY2017 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3169000 | |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
986 | shares |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
3169000 | |
CY2017 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
24089000 | |
CY2017 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
0 | |
CY2017 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
12519000 | |
CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <i>Concentration of Credit Risk</i></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed federally insured limits.</p> </div> | |
CY2017 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
39000 | |
CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
39000 | |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-10.44 | |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.011 | pure |
CY2017 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
1812000 | |
CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-3643000 | |
CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
76000 | |
CY2017 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
214000 | |
CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
138000 | |
CY2017 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | |
CY2017 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2017 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | |
CY2017 | dei |
Document Type
DocumentType
|
10-K | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.001 | pure |
CY2017 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-12-31 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.004 | pure |
CY2017 | dei |
Entity Registrant Name
EntityRegistrantName
|
SELLAS LIFE SCIENCES GROUP, INC. | |
CY2017 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2017 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001390478 | |
CY2017 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.003 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.344 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.002 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.014 | pure |
CY2017 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2017 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2017 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1914000 | |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
265000 | |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-23501000 | |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-23766000 | |
CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2374000 | |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
253000 | |
CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
8366000 | |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-73000 | |
CY2017 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-462000 | |
CY2017 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
941000 | |
CY2017 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
200000 | |
CY2017 | us-gaap |
Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
|
1300000 | |
CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-24429000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1812000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5534000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10989000 | |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23754000 | |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23039000 | |
CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6007000 | |
CY2017 | us-gaap |
Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
|
5200000 | |
CY2017 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
473000 | |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6067000 | |
CY2017 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
449000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
52.94 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1240.55 | |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3169000 | |
CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
15089000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
55000 | shares |
CY2017 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
12487000 | |
CY2017 | us-gaap |
Severance Costs1
SeveranceCosts1
|
1883000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10000 | shares |
CY2017 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.03 | pure |
CY2017 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1294000 | |
CY2017 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
Immediately prior to the Merger, the Galena effected a 1-for-30 reverse stock split of the Company’s outstanding common stock. | |
CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6007000 | |
CY2017 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
28000 | |
CY2017 | dei |
Trading Symbol
TradingSymbol
|
SLS | |
CY2017 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
44000 | |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2340368 | shares |
CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1200000 | |
CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <i>Use of Estimates</i></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, the fair value of the warrants, beneficial conversion features associated with convertible notes, fair value of intangible assets acquired, carrying value of goodwill, fair value of contingent purchase price consideration, fair value of deferred tax liability assumed and accounting for research and development activities. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</p> </div> | |
CY2017 | sls |
Litigation Settlement Amount Cash
LitigationSettlementAmountCash
|
50000 | |
CY2017 | sls |
Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
|
258000 | |
CY2017 | sls |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | |
CY2017 | sls |
Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
|
1309000 | |
CY2017 | sls |
Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
|
316000 | shares |
CY2017 | sls |
Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
|
0 | shares |
CY2017 | sls |
Class Of Warrant Or Right Assumed In Acquisition
ClassOfWarrantOrRightAssumedInAcquisition
|
647000 | shares |
CY2017 | sls |
Operating Loss Carryforwards Expiration Year Range Start
OperatingLossCarryforwardsExpirationYearRangeStart
|
2027 | |
CY2017 | sls |
Operating Loss Carryforwards Expiration Year Range End
OperatingLossCarryforwardsExpirationYearRangeEnd
|
2027 | |
CY2017 | sls |
Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
|
5.15 | |
CY2017 | sls |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
0.011 | pure |
CY2017 | sls |
Fair Valueof Warrants Granted
FairValueofWarrantsGranted
|
0 | |
CY2017 | sls |
Issuanceof Common Stockfor Litigation Settlement
IssuanceofCommonStockforLitigationSettlement
|
1250000 | |
CY2017 | sls |
Shares Issued In Connection With Acquisition
SharesIssuedInConnectionWithAcquisition
|
12487000 | |
CY2017 | sls |
Fair Value Of Stock Options Assumed In Connection With Acquisition
FairValueOfStockOptionsAssumedInConnectionWithAcquisition
|
32000 | |
CY2017 | sls |
Stock Issued In Connection With Amendments To License During Period Value
StockIssuedInConnectionWithAmendmentsToLicenseDuringPeriodValue
|
388000 | |
CY2017 | sls |
Stock Issued During Period Value Settlement Of Related Party Accounts Payable
StockIssuedDuringPeriodValueSettlementOfRelatedPartyAccountsPayable
|
378000 | |
CY2017 | sls |
Stock Issued For Anti Dilution Provisions
StockIssuedForAntiDilutionProvisions
|
61000 | |
CY2017 | sls |
Stock Issued For Incentive Fee Payment In Connection With Acquisition During Period
StockIssuedForIncentiveFeePaymentInConnectionWithAcquisitionDuringPeriod
|
941000 | |
CY2017 | sls |
Shares And Common Stock Warrants Issued Upon Conversion Of Notes During Period
SharesAndCommonStockWarrantsIssuedUponConversionOfNotesDuringPeriod
|
6739000 | |
CY2017 | sls |
Business Combination Pro Forma Transaction Costs
BusinessCombinationProFormaTransactionCosts
|
8700000 | |
CY2017 | sls |
Business Combination Fair Value Of Shares Outstanding
BusinessCombinationFairValueOfSharesOutstanding
|
12487000 | |
CY2017 | sls |
Business Combination Estimated Fair Value Of Stock Options Outstanding
BusinessCombinationEstimatedFairValueOfStockOptionsOutstanding
|
32000 | |
CY2017 | sls |
Adjustments To Additional Paid In Capital Stock Options Exercised In Connection With Acquisition
AdjustmentsToAdditionalPaidInCapitalStockOptionsExercisedInConnectionWithAcquisition
|
32000 | |
CY2017 | sls |
Shares Issued To Settler Elated Party Accounts Payable
SharesIssuedToSettlerElatedPartyAccountsPayable
|
228000 | |
CY2017 | sls |
Shares Issued To Settle Accounts Payable
SharesIssuedToSettleAccountsPayable
|
150000 | |
CY2017 | sls |
Deemed Dividend Associated With Conversion Of Note And Common Stock Warrant Issuance
DeemedDividendAssociatedWithConversionOfNoteAndCommonStockWarrantIssuance
|
675000 | |
CY2017 | sls |
Operating Loss And Tax Credit Carryforwards Limitations On Use Minimum Change In Ownership Percentage
OperatingLossAndTaxCreditCarryforwardsLimitationsOnUseMinimumChangeInOwnershipPercentage
|
0.50 | pure |
CY2017 | sls |
Maximum Indefinitelived Deferred Tax Liability As Percentage Of Net Operating Loss
MaximumIndefinitelivedDeferredTaxLiabilityAsPercentageOfNetOperatingLoss
|
0.80 | pure |
CY2017 | sls |
Operating Loss And Tax Credit Carryforwards Limitations On Use Period Of Ownership Percentage
OperatingLossAndTaxCreditCarryforwardsLimitationsOnUsePeriodOfOwnershipPercentage
|
P3Y | |
CY2017 | sls |
Deemed Dividend On Debt Conversion
DeemedDividendOnDebtConversion
|
675000 | |
CY2017 | sls |
Adjustments To Additional Paid In Capital Deemed Dividend On Debt Conversion
AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnDebtConversion
|
-675000 | |
CY2017 | sls |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Assumed In Acquisition Grant Date Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedInAcquisitionGrantDateIntrinsicValue
|
0 | |
CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
354000 | |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
122 | shares |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
354000 | |
CY2016 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
28389000 | |
CY2016 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
0 | |
CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
4565000 | |
CY2016 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-85000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
16500000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11850000 | |
CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
42000 | |
CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
42000 | |
CY2016 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-41000 | |
CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-41000 | |
CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-41000 | |
CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3000 | |
CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-18.66 | |
CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.104 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.255 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.020 | pure |
CY2016 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-201000 | |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
108000 | |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-17680000 | |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-17788000 | |
CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1830000 | |
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000 | |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
477000 | |
CY2016 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
85000 | |
CY2016 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-1166000 | |
CY2016 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
200000 | |
CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-17681000 | |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17681000 | |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15988000 | |
CY2016 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
526000 | |
CY2016 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
1166000 | |
CY2016 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
15000000 | |
CY2016 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
1500000 | |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
11395000 | |
CY2016 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
1974000 | |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
354000 | |
CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4593000 | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
38.03 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
52.94 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
55000 | shares |
CY2016 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
15411000 | |
CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
947401 | shares |
CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1800000 | |
CY2016 | sls |
Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
|
821000 | |
CY2016 | sls |
Stock Issued During Period Value License Agreement
StockIssuedDuringPeriodValueLicenseAgreement
|
1976000 | |
CY2016 | sls |
Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
|
8.61 | |
CY2016 | sls |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
0.001 | pure |
CY2016 | sls |
Stock Issued During Period Value Partial Consideration Of License Fee
StockIssuedDuringPeriodValuePartialConsiderationOfLicenseFee
|
900000 | |
CY2016 | sls |
Stock Issued In Cancellation Of License Agreement During Period Value
StockIssuedInCancellationOfLicenseAgreementDuringPeriodValue
|
502000 | |
CY2016 | sls |
Stock Issued During Period Value Cancellation Of Long Term Debt
StockIssuedDuringPeriodValueCancellationOfLongTermDebt
|
5803000 |